obesity drug news today october 21 2025 glp-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo How GLP-1s Are Shaping Beauty

Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury

Symptoms are most common during the first few weeks or after dose increases and tend to improve over time

Abstract Chronic kidney disease (CKD) remains a major public health problem, with type 2 diabetes and obesity representing key risk factors worldwide

Baviera M, Foresta A, Colacioppo P, Macaluso G, Roncaglioni MC, Tettamanti M, Fortino I, Genovese S, Caruso I, Giorgino F

[...] Long-Term Weight Loss Solutions Learn about the power of surgical weight loss, including the three laparoscopic weight loss surgery options, the top four benefits of weight loss surgery, and whether bariatric surgery is right for you